Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06101017 · ClinicalTrials.gov registry record
Developing a Nationwide Registry to Track Longitudinal Clinical Outcomes of Corneal Surgery and Disease
A clinical trial of Corneal Disease and Corneal Transplant Failure, sponsored by Nitin Vaswani.
- Completed
- Registry status
- 19
- Enrollment target
- 1
- Study location
NCT06101017: Completed study of Corneal Disease and Corneal Transplant Failure, sponsored by Nitin Vaswani.
NCT06101017 is a study of Corneal Disease and Corneal Transplant Failure that has completed, run by Nitin Vaswani. The registered enrollment target is 19 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06101017, a study of Corneal Disease and Corneal Transplant Failure, has completed, sponsored by Nitin Vaswani.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal is to develop a nationwide registry to track longitudinal clinical outcomes of and store imaging data related to numerous corneal conditions. There are two main objectives including the establishment of the first nationwide corneal transplant registry in the United States to include information related to the donor tissue, recipient, surgical procedure, and long-term clinical outcomes. Ultimately, this prospective data collection will allow us to determine prognostic factors for successful corneal transplantation and create an algorithm to guide clinical practice based on real world outcomes. The second objective is to collect and create a database of historical, de-identified optical coherence topography (OCT) and corneal topography images to ultimately develop artificial intelligence (AI) based diagnostic and prognostic algorithms for corneal disease and surgery.
Primary Outcome
Measurements of individual corneal layers including the epithelium, Bowman's layer, stroma, Descemet's membrane, and endothelium. Overall corneal thickness from anterior to posterior surface.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Optical Coherence Tomography
Study Locations (1)
Maryland
- Keratoplasty Alliance International - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2023-10-12 |
| Est. Completion | 2024-08-15 |
What the finished NCT06101017 record still lists
NCT06101017 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 4 conditions, with Corneal Disease appearing as the primary indexed condition, and to 1 intervention - of which Optical Coherence Tomography is the first listed.
NCT06101017 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06101017 about?
NCT06101017 is a clinical study titled "Developing a Nationwide Registry to Track Longitudinal Clinical Outcomes of Corneal Surgery and Disease". The goal is to develop a nationwide registry to track longitudinal clinical outcomes of and store imaging data related to numerous corneal conditions. There are two main objectives including the establishment of the first nationwide corneal transplant registry in the United States to include informa...
What is the current status of trial NCT06101017?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2023-10-12. Estimated completion is 2024-08-15.
What conditions does trial NCT06101017 study?
This clinical trial studies the following conditions: Corneal Disease, Corneal Transplant Failure, Endothelial Corneal Dystrophy, Corneal Transplant Rejection.
What interventions are being tested in trial NCT06101017?
The interventions under investigation include: Optical Coherence Tomography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06101017?
This trial is sponsored by Nitin Vaswani, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06101017 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Corneal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI